相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
Hao Li et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
Wei Zhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
Bin Bao et al.
CANCER PREVENTION RESEARCH (2012)
Lysine-specifiic histone demethylase 1 (LSD1): A potential molecular target for tumor therapy
Yingwei Chen et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2012)
RNA-Directed Epigenomic Reprogramming-An Emerging Principle of a More Targeted Cancer Therapy?
Evgeny A. Moskalev et al.
GENES CHROMOSOMES & CANCER (2012)
Non-coding RNAs with essential roles in neurodegenerative disorders
Evgenia Salta et al.
LANCET NEUROLOGY (2012)
Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1
H. Chaib et al.
LEUKEMIA (2012)
miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
Wei Zhu et al.
MEDICAL ONCOLOGY (2012)
MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
Soichiro Yamamura et al.
PLOS ONE (2012)
MicroRNA profiling in K-562 cells under imatinib treatment: influence of miR-212 and miR-328 on ABCG2 expression
Eleonora Turrini et al.
PHARMACOGENETICS AND GENOMICS (2012)
The huge world of small RNAs: Regulating networks of microRNAs (Review)
Zs Racz et al.
ACTA PHYSIOLOGICA HUNGARICA (2011)
MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
Zhao-Xia Wang et al.
ARCHIVES OF MEDICAL RESEARCH (2011)
miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells
Akira Tomokuni et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells
Xin Li et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Epigenetic inactivation of the MIR34B/C in multiple myeloma
Kwan Yeung Wong et al.
BLOOD (2011)
Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy
Scott Thomas et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
Hye-Min Jeon et al.
CANCER RESEARCH (2011)
Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
Jing Wang et al.
CANCER RESEARCH (2011)
Epigenetic aberrations during oncogenesis
Maria Hatziapostolou et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
MicroRNA-146a Downregulates NFκB Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma
Jin Ho Paik et al.
CLINICAL CANCER RESEARCH (2011)
Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Yinghua Zhu et al.
CLINICAL CANCER RESEARCH (2011)
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea et al.
DRUG RESISTANCE UPDATES (2011)
The early life social environment and DNA methylation DNA methylation mediating the long-term impact of social environments early in life
Moshe Szyf
EPIGENETICS (2011)
Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study
A. Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
Haitao Bai et al.
FEBS LETTERS (2011)
The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response
Wendy Bernhard et al.
FEBS LETTERS (2011)
Circulating MicroRNAs as Potential Markers of Human Drug-Induced Liver Injury
Philip J. Starkey Lewis et al.
HEPATOLOGY (2011)
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
Chang Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
Dan-Dan Feng et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
Xiaoyu Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development
Yusuke Suzuki et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Non-coding RNAs in cancer initiation and progression and as novel biomarkers
S. Patrick Nana-Sinkam et al.
MOLECULAR ONCOLOGY (2011)
Down-Regulation of ATP-Binding Cassette C2 Protein Expression in HepG2 Cells after Rifampicin Treatment Is Mediated by MicroRNA-379
Sierk Haenisch et al.
MOLECULAR PHARMACOLOGY (2011)
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
Melissa M. Singh et al.
NEURO-ONCOLOGY (2011)
MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
X. Rao et al.
ONCOGENE (2011)
A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma
Tabraiz A. Mohammed et al.
ONCOLOGIST (2011)
Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
Michiel Smits et al.
PLOS ONE (2011)
Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
Dara Nalls et al.
PLOS ONE (2011)
Epigenetics in neurodegeneration: A new layer of complexity
Sueli C. F. Marques et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
MicroRNAs in the Pathogenesis of Cancer
Francesca Lovat et al.
SEMINARS IN ONCOLOGY (2011)
Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
Markus Vogt et al.
VIRCHOWS ARCHIV (2011)
Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
Rosalyn A. Juergens et al.
CANCER DISCOVERY (2011)
Viruses, microRNAs, and Host Interactions
Rebecca L. Skalsky et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010 (2010)
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
Zhongxing Liang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The involvement of microRNAs in Type 2 diabetes
David Ferland McCullough et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation
Xiaoqing Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts
Anna M. Eiring et al.
CELL (2010)
Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
Hongwei Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
Zhimin Li et al.
GYNECOLOGIC ONCOLOGY (2010)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
Laura Poliseno et al.
NATURE (2010)
Targeting microRNAs in cancer: rationale, strategies and challenges
Ramiro Garzon et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Epigenetic phenomena linked to diabetic complications
Luciano Pirola et al.
NATURE REVIEWS ENDOCRINOLOGY (2010)
Histone H1 null vertebrate cells exhibit altered nucleosome architecture
Hideharu Hashimoto et al.
NUCLEIC ACIDS RESEARCH (2010)
MiR-34a Attenuates Paclitaxel-Resistance of Hormone-Refractory Prostate Cancer PC3 Cells Through Direct and Indirect Mechanisms
Keitaro Kojima et al.
PROSTATE (2010)
miR-34a as part of the resistance network in chronic lymphocytic leukemia
Thorsten Zenz et al.
BLOOD (2009)
MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
Yunqing Li et al.
CANCER RESEARCH (2009)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
Kenneth K. W. To et al.
MOLECULAR CANCER THERAPEUTICS (2009)
MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
Yu-Zhuo Pan et al.
MOLECULAR PHARMACOLOGY (2009)
Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
Rulun Zhou et al.
NEUROPSYCHOPHARMACOLOGY (2009)
Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation
Erbo Dong et al.
EPIGENOMICS (2009)
Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Preethi H. Gunaratne
CURRENT STEM CELL RESEARCH & THERAPY (2009)
MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
Yu-Zhuo Pan et al.
DRUG METABOLISM AND DISPOSITION (2009)
Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
Moshe Szyf
Annual Review of Pharmacology and Toxicology (2008)
Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
Hua Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression
Maria J. Bueno et al.
CANCER CELL (2008)
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
Lin Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNA-221/222 Negatively Regulates Estrogen Receptor α and Is Associated with Tamoxifen Resistance in Breast Cancer
Jian-Jun Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNAs play a role in the development of human hematopoietic stem cells
Rongxia Liao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Regulation of ABCG2 expression at the 3 ' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative MicroRNA in the s1 colon cancer cell line
Kenneth K. W. To et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Olga Kovalchuk et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
Carlos le Sage et al.
EMBO JOURNAL (2007)
The role of microRNAs in cancer: No small matter
Erik A. C. Wiemer
EUROPEAN JOURNAL OF CANCER (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
Mechanisms of Disease: methyl-binding domain proteins as potential therapeutic targets in cancer
Owen J. Sansom et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells
Andelko Hrzenjak et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Rapid alteration of microRNA levels by histone deacetylase inhibition
GK Scott et al.
CANCER RESEARCH (2006)
Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
D Greiner et al.
NATURE CHEMICAL BIOLOGY (2005)
MicroRNA binding sites in Arabidopsis class IIIHD-ZIP mRNAs are required for methylation of the template chromosome
N Bao et al.
DEVELOPMENTAL CELL (2004)
分享论文
